Browse the full management transaction log of 케이엠제약, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €15bn. The latest transaction was reported on 9 April 2026 (Purchase). Among the most active insiders: 강일모. The full history is openly available.